Claritev (CTEV)

Profile

Full Name

CTEV

Ticker Symbol

CTEV

Exchange

NYSE

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

April 3, 2020

Indexes

Not included

Website

http://www.claritev.com

Employees

2700

Key Details

Price

$19.67(-0.10%)

Market cap

$318.61M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$930.62M(-3.21% YoY)

Annual EPS

-$101.92(-1691.21% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$19.67
CTEV price is $19.67

30-Day Relative Volume

0.89
CTEV 30-day relative volume is 0.89

Price Performance

Price Most recent change

-0.1%
CTEV price was down -0.1% on Apr 10, 2025

Price YTD change

+33.09%
CTEV price is up +33.09% since January 1st

Price 1-year change

-39.14%
CTEV price is down -39.14% year-on-year

Price 3-year change

-89.63%
CTEV price is down -89.63% over the past 3 years

Price Range

Price All-time high

$517.20
CTEV price is currently -96.20% below its historical high of $517.20

Price 3-year low

$4.80
CTEV price is currently +309.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$318.61M
CTEV market capitalization is $318.61 million

Market cap 3-year change

-89.48%
CTEV market capitalization is down -89.48% over the past 3 years

Market cap All-time high

$16.13B
CTEV market capitalization is currently -98.03% below its historical high of $16.13 billion

Market cap sector rank

63.85%
CTEV market capitalization is higher than 63.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.58%
CTEV shares outstanding is up +0.58% year-on-year

Shares Outstanding 3-Year Change

+1.41%
CTEV shares outstanding is up +1.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.27
CTEV beta is 1.27

200-day SMA

$13.67
CTEV price is currently +43.94% above its 200-day simple moving average

50-day SMA

$21.75
CTEV price is currently -9.58% below its 50-day simple moving average

RSI

44.84
CTEV 14-day relative strength index is 44.84

Volume

0.89
CTEV 30-day relative volume is 0.89

ATR

$1.74
CTEV average true range is $1.74

10-day Historical Volatility

39.02%
CTEV 10-day historical volatility is 39.02%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$930.62M
CTEV annual revenue is $930.62 million

Revenue Analysts estimate

$922.67M
CTEV annual revenue is currently +0.86% higher than the consensus analysts' forecast

Revenue 1-year change

-3.21%
CTEV annual revenue is down -3.21% year-on-year

Revenue Sector rank

-
CTEV annual revenue is unknown

EPS

EPS

-$101.92
CTEV annual earnings per share is -$101.92

EPS Analysts estimate

-$8.06
CTEV annual earnings per share is currently +1164.52% higher than the consensus analysts' forecast

EPS 1-year change

-1691.21%
CTEV annual earnings per share is down -1691.21% year-on-year

EPS Sector rank

-
CTEV annual earnings per share is unknown

Profit

Gross profit

$691.22M
CTEV annual gross profit is $691.22 million

Gross margin

74.27%
CTEV annual gross profit margin is 74.27%

Operating profit

$98.93M
CTEV annual operating income is $98.93 million

Operating margin

10.63%
CTEV annual operating profit margin is 10.63%

Net income

-$1.65B
CTEV annual net profit is -$1.65 billion

Net margin

-176.85%
CTEV annual net profit margin is -176.85%

Expenses

Total expenses

$831.69M
CTEV annual total expenses is $831.69 million

Operating expenses

$592.29M
CTEV annual total operating expenses is $592.29 million

Cost of goods sold

$239.40M
CTEV annual cost of goods sold is $239.40 million

Selling, general & administrative expenses

$160.22M
CTEV annual SGA is $160.22 million

Depreciation and amortization

$436.44M
CTEV annual depreciation & amortization is $436.44 million

Interest expense

$326.37M
CTEV annual interest expense is $326.37 million

Income tax

-$124.88M
CTEV annual income tax is -$124.88 million

EBIT & EBITDA

EBIT

-$1.44B
CTEV annual earnings before interest & taxes is -$1.44 billion

EBITDA

-$1.01B
CTEV annual EBITDA is -$1.01 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.15B
CTEV annual total assets is $5.15 billion

Non current assets

$4.98B
CTEV annual long term assets is $4.98 billion

Current assets

$175.51M
CTEV annual total current assets is $175.51 million

Cash and cash equivalents

$16.85M
CTEV annual cash & cash equivalents is $16.85 million

Accounts receivable

$89.76M
CTEV annual accounts receivable is $89.76 million

Inventory

-
CTEV annual inventory value is unknown

Liabilities

Total liabilities

$5.07B
CTEV annual total liabilities is $5.07 billion

Long term liabilities

$4.85B
CTEV annual total long term liabilities is $4.85 billion

Current liabilities

$213.79M
CTEV annual total current liabilities is $213.79 million

Accounts payable

$86.33M
CTEV annual accounts payable is $86.33 million

Debt

Total debt

$4.54B
CTEV annual total debt is $4.54 billion

Total debt 1-year change

-0.58%
CTEV annual total debt is down -0.58% year-on-year

Long term debt

$4.52B
CTEV annual long term debt is $4.52 billion

Short term debt

$17.64M
CTEV annual short term debt is $17.64 million

Equity & Capital

Shareholders equity

$84.02M
CTEV annual stockholders equity is $84.02 million

Book value

$84.02M
CTEV annual book value is $84.02 million

Retained earnings

-$2.15B
CTEV annual retained earnings is -$2.15 billion

Working capital

-$38.27M
CTEV annual working capital is -$38.27 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$107.62M
CTEV annual cash flow from operations is $107.62 million

Cash from operations 1-year change

-37.33%
CTEV annual cash flow from operations is down -37.33% year-on-year

Cash from investing

-$118.12M
CTEV annual cash flow from investing activities is -$118.12 million

Cash from investing 1-year change

+52.71%
CTEV annual cash flow from investing activities is up +52.71% year-on-year

Cash from financing

-$41.31M
CTEV annual cash flow from financing activities is -$41.31 million

Cash from financing 1-year change

+77.17%
CTEV annual cash flow from financing activities is up +77.17% year-on-year

CAPEX

CAPEX

$118.12M
CTEV annual capital expenditures is $118.12 million

CAPEX 1-year change

+8.52%
CTEV annual capital expenditures is up +8.52% year-on-year

Free Cash Flow

Free cash flow

-$10.51M
CTEV annual free cash flow is -$10.51 million

Free cash flow 1-year change

-116.71%
CTEV annual free cash flow is down -116.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

74.27%
CTEV annual gross profit margin is 74.27%

Operating margin

10.63%
CTEV annual operating profit margin is 10.63%

Net margin

-176.85%
CTEV annual net profit margin is -176.85%

ROA & ROE

ROA

-27.17%
CTEV annual return on assets is -27.17%

ROE

-183.57%
CTEV annual return on equity is -183.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CTEV price to earnings ratio value is unknown

PE ratio Sector rank

-
CTEV price to earnings ratio is unknown

PB Ratio

PB ratio

3.79
CTEV price to book ratio is 3.79

PB ratio Sector rank

78.21%
CTEV price to book ratio is higher than 78.21% of companies in Healthcare sector

PS Ratio

PS ratio

0.34
CTEV price to sales ratio is 0.34

PS ratio Sector rank

11.67%
CTEV price to sales ratio is higher than 11.67% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.84B
CTEV enterprise value is $4.84 billion

Enterprise value Sector rank

88.05%
CTEV enterprise value is higher than 88.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.81
CTEV EV/EBITDA is -4.81

EV/EBITDA Sector rank

18.75%
CTEV EV/EBITDA is higher than 18.75% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.82
CTEV annual current ratio is 0.82

Quick ratio

-
CTEV annual quick ratio value is unknown

Leverage

Debt to equity

53.83
CTEV annual debt to equity ratio is 53.83

Interest coverage ratio

-4.43
CTEV annual interest coverage ratio is -4.43

Risk & Stability

Piotroski F-Score

6
CTEV piotroski f-score is 6

Altman Z-Score

-1.30
CTEV altman z-score is -1.30

Analyst ratings

Recent major analysts updates

Mar 10, 25 Piper Sandler
Neutral
Jan 10, 25 Citigroup
Neutral
Sep 23, 24 Citigroup
Neutral

Institutional Ownership

Similar stocks

MPLN logo
MultiPlan (MPLN)
VREX logo
Varex Imaging (VREX)
TCMD logo
Tactile Systems Technology (TCMD)
ALT logo
Altimmune (ALT)
ETON logo
Eton Pharmaceuticals (ETON)
Rapport Therapeutics (RAPP)
PRTC logo
PureTech Health (PRTC)
SMLR logo
Semler Scientific (SMLR)
ABSI logo
Absci (ABSI)
  • What is the ticker symbol for Claritev?
  • Does Claritev pay dividends?
  • What sector is Claritev in?
  • What industry is Claritev in?
  • What country is Claritev based in?
  • When did Claritev go public?
  • Is Claritev in the S&P 500?
  • Is Claritev in the NASDAQ 100?
  • Is Claritev in the Dow Jones?
  • When was Claritev's last earnings report?
  • When does Claritev report earnings?

What is the ticker symbol for Claritev?

The ticker symbol for Claritev is NYSE:CTEV

Does Claritev pay dividends?

No, Claritev does not pay dividends

What sector is Claritev in?

Claritev is in the Healthcare sector

What industry is Claritev in?

Claritev is in the Health Information Services industry

What country is Claritev based in?

Claritev is headquartered in United States

When did Claritev go public?

Claritev's initial public offering (IPO) was on April 3, 2020

Is Claritev in the S&P 500?

No, Claritev is not included in the S&P 500 index

Is Claritev in the NASDAQ 100?

No, Claritev is not included in the NASDAQ 100 index

Is Claritev in the Dow Jones?

No, Claritev is not included in the Dow Jones index

When was Claritev's last earnings report?

Claritev's most recent earnings report was on Feb 25, 2025

When does Claritev report earnings?

The next expected earnings date for Claritev is May 8, 2025
On this page